Find clinical trials for AbbVie. Search for AbbVie clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 91
New
Study to Assess Participant Satisfaction After Jawline and Neck Treatment
for
Jawline and Neck Appearance
Location: Toronto, Vancouver
Sponsor: AbbVie
Sex: All
Age: 22 - 65
Code: NCT07794891
Recruiting
New
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
for
Healthy Volunteers
Location: Grayslake IL
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07843693
Phase 1, Recruiting
New
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for
Head and Neck Squamous Cell Carcinoma
Location: Newnan GA, Duarte CA
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07744126
Phase 2, Recruiting
Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries
for
Ovarian Cancer
Location: Toronto
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07539844
Recruiting
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
for
Glabellar Lines
Location: Chestnut Hill MA, Wilmington NC, Nashville TN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07756580
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder
for
Bipolar Disorder
Location: Los Alamitos CA
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07071532
Phase 1, Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants
for
Healthy Volunteer
Location: Grayslake IL, Anaheim CA
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07736638
Phase 1, Recruiting
FeaturedActive & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: New York NY, Hollywood FL, Miami FL, Orlando FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase 2, Recruiting
FeaturedActive & Responsive
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
for
Migraine
Location: Miami FL, Los Angeles CA, Summerville SC, Tampa FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 70
Code: NCT06602479
Phase 2, Recruiting
FeaturedActive & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Cromwell CT, Springfield MA, Brooklyn NY, Toms River NJ,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase 2, Recruiting
FeaturedActive & Responsive
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
for
Mid Face Volume Deficit
Location: New York NY, Latham NY, Baltimore MD, Arlington VA,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT06734351
Phase 3, Recruiting
FeaturedActive & Responsive
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
for
Bipolar I Disorder, Bipolar II Disorder
Location: New York NY, Pompano Beach FL, West Palm Beach FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06696755
Phase 2, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Montreal, Fairfax VA, Durham NC, Toronto,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase 1, Recruiting
Featured
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia (CLL)
Location: Boston MA, Hackensack NJ, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04895436
Phase 2, Recruiting
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: Providence RI, Worcester MA, New Haven CT, New York NY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase 3, Recruiting
Featured
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
for
Hidradenitis Suppurativa, Atopic Dermatitis
Location: Ann Arbor MI, Sacramento CA
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06524635
Phase 2, Recruiting
Featured
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
for
Healthy Volunteers
Location: Grayslake IL
Sponsor: AbbVie
Sex: All
Age: 18 - 60
Code: NCT07306754
Phase 1, Recruiting
Featured
A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
for
Obesity
Location: Grayslake IL, Anaheim CA
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07291232
Phase 1, Recruiting
Featured
A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of Healthy Adult Participants
for
Healthy Volunteer
Location: Miami FL, Anaheim CA
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07466550
Phase 1, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: New Haven CT, New York NY, Fairfax VA, Durham NC,